Trial · NCT00437658
Participant flow21
How many started, completed or left each group, period by period.
1 to 20 of 21
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period (24 Weeks) | STARTED | Elagolix 150 mg QD | 84 | |
| Treatment Period (24 Weeks) | STARTED | Elagolix 75 mg BID | 84 | |
| Treatment Period (24 Weeks) | STARTED | DMPA-SC | 84 | |
| Treatment Period (24 Weeks) | Received Study Drug | Elagolix 150 mg QD | 84 | |
| Treatment Period (24 Weeks) | Received Study Drug | Elagolix 75 mg BID | 84 | |
| Treatment Period (24 Weeks) | Received Study Drug | DMPA-SC | 84 | |
| Treatment Period (24 Weeks) | COMPLETED | Elagolix 150 mg QD | 56 | |
| Treatment Period (24 Weeks) | COMPLETED | Elagolix 75 mg BID | 62 | |
| Treatment Period (24 Weeks) | COMPLETED | DMPA-SC | 51 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Elagolix 150 mg QD | 28 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Elagolix 75 mg BID | 22 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | DMPA-SC | 33 | |
| Post-treatment Period (24 Weeks) | STARTED | Elagolix 150 mg QD | 56 | |
| Post-treatment Period (24 Weeks) | STARTED | Elagolix 75 mg BID | 62 | |
| Post-treatment Period (24 Weeks) | STARTED | DMPA-SC | 51 | |
| Post-treatment Period (24 Weeks) | COMPLETED | Elagolix 150 mg QD | 32 | |
| Post-treatment Period (24 Weeks) | COMPLETED | Elagolix 75 mg BID | 54 | |
| Post-treatment Period (24 Weeks) | COMPLETED | DMPA-SC | 37 | |
| Post-treatment Period (24 Weeks) | NOT COMPLETED | Elagolix 150 mg QD | 24 | |
| Post-treatment Period (24 Weeks) | NOT COMPLETED | Elagolix 75 mg BID | 8 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00437658/flow